Figures
- FIGURE 1
a) Participating intensive care units (ICUs) in the worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) prospective cohort study, by country. b) Patients enrolled in the WEAN SAFE prospective cohort study, by country.
Tables
- TABLE 1
Unanswered questions to be addressed by the worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) study
1 What is the frequency of delayed weaning from IMV? 2 What current approaches are taken to wean patients from IMV? 3 What factors are used to determine when patients are in the weaning phase? 4 What are the barriers to effective weaning from IMV? 5 What are the factors (patient, institutional, medical practice) that contribute to failed attempts to wean from IMV? 6 What is the impact of sedation management on weaning from IMV? 7 What is the impact of pre-morbid conditions and of frailty on weaning from IMV? 8 What is the utility of existing classifications for weaning from IMV? 9 What is the impact of early versus delayed and/or failed weaning from IMV? 10 What is the role of noninvasive ventilation in the weaning process? 11 What regional or geo-economic differences exist regarding weaning from IMV? 12 What is the therapeutic resource use in patients with delayed weaning from IMV? IMV: invasive mechanical ventilation.
Vol 53 Issue 3
Table of Contents
The worldwide assessment of separation of patients from ventilatory assistance (WEAN SAFE) ERS Clinical Research Collaboration
